Page last updated: 2024-12-09

tasiamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tasiamide: a cytotoxic peptide from the marine cyanobacterium Symploca sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID637436
CHEMBL ID451584
SCHEMBL ID2711632
MeSH IDM0445355

Synonyms (6)

Synonym
tasiamide
CHEMBL451584
SCHEMBL2711632
tasiamide a
DTXSID901046482
tasiamid a

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID336132Cytotoxicity against human KB cells2002Journal of natural products, Sep, Volume: 65, Issue:9
Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp.
AID336133Cytotoxicity against human LoVo cells2002Journal of natural products, Sep, Volume: 65, Issue:9
Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp.
AID1129017Cytotoxicity against human KB cells2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Lipopeptides from the tropical marine cyanobacterium Symploca sp.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]